Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine.

@article{Jacob2005EndogenousPT,
  title={Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine.},
  author={M S Jacob and David E Presti},
  journal={Medical hypotheses},
  year={2005},
  volume={64 5},
  pages={
          930-7
        }
}

Figures from this paper

Neuropharmacology of N,N-dimethyltryptamine

A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity

N,N-dimethyltryptamine (DMT) is classified as a naturally occurring serotonergic hallucinogen of plant origin. It has also been found in animal tissues and regarded as an endogenous trace amine

The behavioral pharmacology of hallucinogens.

In Vivo Long-Term Kinetics of Radiolabeled N,N-Dimethyltryptamine and Tryptamine

This is the first demonstration that exogenous DMT remains in the brain for at least 7 d after injection, and the 131I-labeling proved to be a useful tool to perform long-term in vivo studies.

Clinical applications of hallucinogens: A review.

This review will present data on several classes of hallucinogens with a particular focus on psychedelics, entactogens, and dissociatives, for which clinical utility has been most extensively documented, with important ramifications for their potential therapeutic value.

Parapsychology, N,N-Dimethyltryptamine and the Pineal Gland

In the last decades, one of the psychedelic substances which has gained high attention for its implications in several para-psychological phenomena (including out-of-body states, deep changes in

Dimetiltriptamina: alcalóide alucinógeno e seus efeitos no Sistema Nervoso Central

This research aimed to elucidate the mechanisms of action and the effects of DMT present on alumina drinks of the species Mimosa tenuiflora (jurema preta), Banisteriopsis caapi and Psychotria viridis (chacrona) on the CNS, elucidating the risks of their ingestion and information Brazilian legislation.

Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies

Individuals with a personal or family history of any psychotic illness or nonpsychotic mania should avoid hallucinogen intake.

Phenomenology of N,N-Dimethyltryptamine use : a thematic analysis

Abstract—N,N-dimethyltryptamine (DMT) is an endogenous hallucinogeniccompound in the same chemical class as the more common psilocybin and theneurotransmitter serotonin. Despite previous experimental
...

References

SHOWING 1-10 OF 76 REFERENCES

Human psychopharmacology of N,N-dimethyltryptamine

  • R. Strassman
  • Psychology, Biology
    Behavioural Brain Research
  • 1995

N, N-dimethyltryptamine: an endogenous hallucinogen.

Detection of Psychotomimetic N,N-Dimethylated Indoleamines in the Urine of Four Schizophrenic Patients

On the basis of their previous work indicating that tryptamine appeared in increased concentrations in the urine before and during the activation of psychotic symptoms, they suggested that under loading conditions the formation of various N,N-dimethylated indoleamines might be facilitated in the body.

Serotonin and Hallucinogens

Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects.

Dimethyltryptamine can be administered safely to experienced hallucinogen users and dose-response data generated for several measures hypothesized under serotonergic modulatory control may prove useful in psychopharmacological investigations of drug-induced and endogenous alterations in brain function.

Increased excretion of dimethyltryptamine and certain features of psychosis: a possible association.

The excretion of the hallucinogen dimethyltryptamine (DMT) and its precursor N-methyltryptamine (NMT) was studied among 74 recently admitted psychiatric patients and 19 normal persons. Both compounds

Hallucinogenic Drugs in Psychiatric Research and Treatment Perspectives and Prospects

  • R. Strassman
  • Psychology, Medicine
    The Journal of nervous and mental disease
  • 1995
It is critical that human hallucinogen research in the 1990s make use of state of the art methodologies, or consensually define when modifications are required, and training and supervisory issues also must be explicitly addressed.

Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.

The discovery and pharmacological characterization of a rat G protein-coupled receptor that stimulates the production of cAMP when exposed to the trace amines p-tyramine, beta-phenethylamine, tryptamine, and octopamine and the discovery that amphetamines are potent rTAR1 agonists suggests that the effects of these widely used drugs may be mediated in part by this receptor as well as their previously characterized targets, the neurotransmitter transporter proteins.
...